72 related articles for article (PubMed ID: 36396045)
1. Pepsinogen C Interacts with IQGAP1 to Inhibit the Metastasis of Gastric Cancer Cells by Suppressing Rho-GTPase Pathway.
Ding H; Liu Y; Lu X; Liu A; Xu Q; Yuan Y
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791874
[TBL] [Abstract][Full Text] [Related]
2. IQGAP1 mediates the communication between the nucleus and the mitochondria via NDUFS4 alternative splicing.
Papadaki V; Erpapazoglou Z; Kokkori M; Rogalska ME; Potiri M; Birladeanu A; Tsakiri EN; Ashktorab H; Smoot DT; Papanikolopoulou K; Samiotaki M; Kafasla P
NAR Cancer; 2023 Sep; 5(3):zcad046. PubMed ID: 37636315
[TBL] [Abstract][Full Text] [Related]
3. Impaired histone inheritance promotes tumor progression.
Tian C; Zhou J; Li X; Gao Y; Wen Q; Kang X; Wang N; Yao Y; Jiang J; Song G; Zhang T; Hu S; Liao J; Yu C; Wang Z; Liu X; Pei X; Chan K; Liu Z; Gan H
Nat Commun; 2023 Jun; 14(1):3429. PubMed ID: 37301892
[TBL] [Abstract][Full Text] [Related]
4. Targeting Trop2 by Bruceine D suppresses breast cancer metastasis by blocking Trop2/β-catenin positive feedback loop.
Tang W; Hu Y; Tu K; Gong Z; Zhu M; Yang T; Sarwar A; Dai B; Zhang D; Zhan Y; Zhang Y
J Adv Res; 2024 Apr; 58():193-210. PubMed ID: 37271476
[TBL] [Abstract][Full Text] [Related]
5. NOTCH4
Zhang B; Dong S; Wang J; Huang T; Zhao P; Xu J; Liu D; Fu L; Wang L; Wang G; Zou C
Nat Commun; 2023 Jun; 14(1):3183. PubMed ID: 37268635
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance.
Huang C; Ren S; Chen Y; Liu A; Wu Q; Jiang T; Lv P; Song D; Hu F; Lan J; Sun L; Zheng X; Luo X; Chu Q; Jia K; Li Y; Wang J; Zou C; Hu J; Wang G
Sci Adv; 2023 May; 9(21):eade4186. PubMed ID: 37235656
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular nanofibers co-loaded with dabrafenib and doxorubicin for targeted and synergistic therapy of differentiated thyroid carcinoma.
Chen P; Cai X; Mu G; Duan Y; Jing C; Yang Z; Yang C; Wang X
Theranostics; 2023; 13(7):2140-2153. PubMed ID: 37153748
[No Abstract] [Full Text] [Related]
8. FGL2 deficiency alleviates maternal inflammation-induced blood-brain barrier damage by blocking PI3K/NF-κB mediated endothelial oxidative stress.
Huang L; Zhan D; Xing Y; Yan Y; Li Q; Zhang J; Li S; Ning Q; Zhang C; Luo X
Front Immunol; 2023; 14():1157027. PubMed ID: 37051251
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of phosphoserine phosphatase potentiates tumor immune environments to enhance immune checkpoint blockade therapy.
Peng ZP; Liu XC; Ruan YH; Jiang D; Huang AQ; Ning WR; Jiang ZZ; Zheng L; Wu Y
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36849198
[TBL] [Abstract][Full Text] [Related]
10. Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment.
Wang R; Zhang C; Cao Y; Wang J; Jiao S; Zhang J; Wang M; Tang P; Ouyang Z; Liang W; Mao Y; Wang A; Li G; Zhang J; Wang M; Wang S; Gui X
Theranostics; 2023; 13(1):148-160. PubMed ID: 36593962
[No Abstract] [Full Text] [Related]
11. Anti-BCMA surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-κB signaling in vivo.
Xiao X; Ma Z; Li Z; Deng Y; Zhang Y; Xiang R; Zhu L; He Y; Li H; Jiang Y; Zhu Y; Xie Y; Peng H; Liu X; Wang H; Ye M; Zhao Y; Liu J
Biomaterials; 2023 Jun; 297():122096. PubMed ID: 37075614
[TBL] [Abstract][Full Text] [Related]
12. Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche.
Li Y; He M; Zhang W; Liu W; Xu H; Yang M; Zhang H; Liang H; Li W; Wu Z; Fu W; Xu S; Liu X; Fan S; Zhou L; Wang C; Zhang L; Li Y; Gu J; Yin J; Zhang Y; Xia Y; Mao X; Cheng T; Shi J; Du Y; Gao Y
Nat Commun; 2023 Apr; 14(1):2207. PubMed ID: 37072407
[TBL] [Abstract][Full Text] [Related]
13. "Hook&Loop" multivalent interactions based on disk-shaped nanoparticles strengthen active targeting.
Dong N; Liu Z; He H; Lu Y; Qi J; Wu W
J Control Release; 2023 Feb; 354():279-293. PubMed ID: 36641117
[TBL] [Abstract][Full Text] [Related]
14. Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase.
Wang Y; Chen YY; Gao GB; Zheng YH; Yu NN; Ouyang L; Gao X; Li N; Wen SY; Huang S; Zhao Q; Liu L; Cao M; Zhang S; Zhang J; He QY
Mol Ther; 2023 Jul; 31(7):2169-2187. PubMed ID: 37211762
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis.
Xu WW; Liao L; Dai W; Zheng CC; Tan XP; He Y; Zhang QH; Huang ZH; Chen WY; Qin YR; Chen KS; He ML; Law S; Lung ML; He QY; Li B
EBioMedicine; 2023 Jun; 92():104587. PubMed ID: 37149929
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor pracinostat suppresses colorectal cancer by inducing CDK5-Drp1 signaling-mediated peripheral mitofission.
Liang XL; Ouyang L; Yu NN; Sun ZH; Gui ZK; Niu YL; He QY; Zhang J; Wang Y
J Pharm Anal; 2023 Oct; 13(10):1168-1182. PubMed ID: 38024857
[TBL] [Abstract][Full Text] [Related]
17. Targeting ARF1-IQGAP1 interaction to suppress colorectal cancer metastasis and vemurafenib resistance.
Hu HF; Gao GB; He X; Li YY; Li YJ; Li B; Pan Y; Wang Y; He QY
J Adv Res; 2023 Sep; 51():135-147. PubMed ID: 36396045
[TBL] [Abstract][Full Text] [Related]
18. Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission.
Hu HF; Xu WW; Li YJ; He Y; Zhang WX; Liao L; Zhang QH; Han L; Yin XF; Zhao XX; Pan YL; Li B; He QY
Theranostics; 2021; 11(4):1828-1844. PubMed ID: 33408784
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
Yang H; Higgins B; Kolinsky K; Packman K; Bradley WD; Lee RJ; Schostack K; Simcox ME; Kopetz S; Heimbrook D; Lestini B; Bollag G; Su F
Cancer Res; 2012 Feb; 72(3):779-89. PubMed ID: 22180495
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
